Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

Primo sponsors the Executive Master in Management specialized in Healthcare Business

 December

 9, 

2016

En quête d’entreprises profitables

 November

 14, 

2016

ARCHIMED buys four companies; HIS, Fytexia, Polyplus, and Micromed

 September

 20, 

2016

Jayne Carrington discusses mental wellbeing in the workplace

 June

 27, 

2016

ARCHIMED acquires Deallus Consulting

 November

 9, 

2015

ARCHIMED acquires stakes in RehabWorks and Primo

 November

 9, 

2015

< 1 … 14 15 16 17 >
368
  • ARCHIMED © 2026
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top